John Dillon
John Dillon
Verified email at
Cited by
Cited by
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
AK Daly, PT Donaldson, P Bhatnagar, Y Shen, I Pe'er, A Floratos, MJ Daly, ...
Nature genetics 41 (7), 816-819, 2009
Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale‐up in the age of direct‐acting antivirals
NK Martin, P Vickerman, J Grebely, M Hellard, SJ Hutchinson, VD Lima, ...
Hepatology 58 (5), 1598-1609, 2013
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ...
Gastroenterology 141 (1), 338-347, 2011
Guidelines on the management of abnormal liver blood tests
PN Newsome, R Cramb, SM Davison, JF Dillon, M Foulerton, EM Godfrey, ...
Gut 67 (1), 6-19, 2018
Microbial biofilms in the human gastrointestinal tract
S Macfarlane, JF Dillon
Journal of applied microbiology 102 (5), 1187-1196, 2007
MAIT cells are activated during human viral infections
B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ...
Nature communications 7 (1), 11653, 2016
The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis
M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ...
Hepatology 63 (3), 930-950, 2016
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis
S Chowdhry, MH Nazmy, PJ Meakin, AT Dinkova-Kostova, SV Walsh, ...
Free Radical Biology and Medicine 48 (2), 357-371, 2010
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ...
The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis
RD Grose, J Nolan, JF Dillon, M Errington, WJ Hannan, IAD Bouchier, ...
Journal of hepatology 22 (3), 326-332, 1995
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices
R Jalan, EH Forrest, AJ Stanley, DN Redhead, J Forbes, JF Dillon, ...
Hepatology 26 (5), 1115-1122, 1997
The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations
JV Lazarus, K Safreed-Harmon, MR Thursz, JF Dillon, MH El-Sayed, ...
Seminars in liver disease 38 (03), 181-192, 2018
Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein …
PJ Meakin, S Chowdhry, RS Sharma, FB Ashford, SV Walsh, ...
Molecular and cellular biology 34 (17), 3305-3320, 2014
Oesophageal bacterial biofilm changes in gastro‐oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?
KL Blackett, SS Siddhi, S Cleary, H Steed, MH Miller, S Macfarlane, ...
Alimentary pharmacology & therapeutics 37 (11), 1084-1092, 2013
Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study
P Nicoletti, GP Aithal, ES Bjornsson, RJ Andrade, A Sawle, M Arrese, ...
Gastroenterology 152 (5), 1078-1089, 2017
Paracetamol toxicity: epidemiology, prevention and costs to the health‐care system
CL Sheen, JF Dillon, DN Bateman, KJ Simpson, TM Macdonald
Qjm 95 (9), 609-619, 2002
Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus
S Macfarlane, E Furrie, GT Macfarlane, JF Dillon
Clinical infectious diseases 45 (1), 29-38, 2007
Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-related factor 2)
RS Sharma, DJ Harrison, D Kisielewski, DM Cassidy, AD McNeilly, ...
Cellular and molecular gastroenterology and hepatology 5 (3), 367-398, 2018
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK
R Williams, G Alexander, I Armstrong, A Baker, N Bhala, G Camps-Walsh, ...
The Lancet 391 (10125), 1097-1107, 2018
Systematic review: health-state utilities in liver disease: a systematic review
DJ McLernon, J Dillon, PT Donnan
Medical Decision Making 28 (4), 582-592, 2008
The system can't perform the operation now. Try again later.
Articles 1–20